LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 5 of total 5

Search options

  1. Article ; Online: Resolution of Persistent COVID-19 After Convalescent Plasma in a Patient with B Cell Aplasia.

    McKemey, Emily / Shields, Adrian M / Faustini, Sian E / Hill, Harriet J / Barnskaya, Aliaksandra / Stamataki, Zania / Gompertz, Simon / Richter, Alex G / Dosanjh, Davinder / Madathil, Shyam

    Journal of clinical immunology

    2021  Volume 41, Issue 5, Page(s) 926–929

    MeSH term(s) B-Lymphocytes ; COVID-19/therapy ; Coronavirus Infections ; Humans ; Immunization, Passive ; SARS-CoV-2
    Language English
    Publishing date 2021-02-20
    Publishing country Netherlands
    Document type Letter ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 779361-3
    ISSN 1573-2592 ; 0271-9142
    ISSN (online) 1573-2592
    ISSN 0271-9142
    DOI 10.1007/s10875-021-00996-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Correction to: Resolution of Persistent COVID-19 After Convalescent Plasma in a Patient with B Cell Aplasia.

    McKemey, Emily / Shields, Adrian M / Faustini, Sian E / Hill, Harriet J / Baranskaya, Aliaksandra / Stamataki, Zania / Gompertz, Simon / Richter, Alex G / Dosanjh, Davinder / Madathil, Shyam

    Journal of clinical immunology

    2021  Volume 41, Issue 5, Page(s) 930

    Language English
    Publishing date 2021-03-26
    Publishing country Netherlands
    Document type Published Erratum
    ZDB-ID 779361-3
    ISSN 1573-2592 ; 0271-9142
    ISSN (online) 1573-2592
    ISSN 0271-9142
    DOI 10.1007/s10875-021-01029-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Pulmonary function test and computed tomography features during follow-up after SARS, MERS and COVID-19: a systematic review and meta-analysis.

    Huntley, Christopher C / Patel, Ketan / Bil Bushra, Shahnoor-E-Salam / Mobeen, Farah / Armitage, Michael N / Pye, Anita / Knight, Chloe B / Mostafa, Alyaa / Kershaw, Marie / Mughal, Aishah Z / McKemey, Emily / Turner, Alice M / Burge, P Sherwood / Walters, Gareth I

    ERJ open research

    2022  Volume 8, Issue 2

    Abstract: Background: The COVID-19 pandemic follows severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronavirus epidemics. Some survivors of COVID-19 infection experience persistent respiratory symptoms, yet their cause and ... ...

    Abstract Background: The COVID-19 pandemic follows severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronavirus epidemics. Some survivors of COVID-19 infection experience persistent respiratory symptoms, yet their cause and natural history remain unclear. Follow-up after SARS and MERS may provide a model for predicting the long-term pulmonary consequences of COVID-19.
    Methods: This systematic review and meta-analysis aims to describe and compare the longitudinal pulmonary function test (PFT) and computed tomography (CT) features of patients recovering from SARS, MERS and COVID-19. Meta-analysis of PFT parameters (DerSimonian and Laird random-effects model) and proportion of CT features (Freeman-Tukey transformation random-effects model) were performed.
    Findings: Persistent reduction in the diffusing capacity for carbon monoxide following SARS and COVID-19 infection is seen at 6 months follow-up, and 12 months after MERS. Other PFT parameters recover in this time. 6 months after SARS and COVID-19, ground-glass opacity, linear opacities and reticulation persist in over 30% of patients; honeycombing and traction dilatation are reported less often. Severe/critical COVID-19 infection leads to greater CT and PFT abnormality compared to mild/moderate infection.
    Interpretation: Persistent diffusion defects suggestive of parenchymal lung injury occur after SARS, MERS and COVID-19 infection, but improve over time. After COVID-19 infection, CT features are suggestive of persistent parenchymal lung injury, in keeping with a post-COVID-19 interstitial lung syndrome. It is yet to be determined if this is a regressive or progressive disease.
    Language English
    Publishing date 2022-05-30
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2827830-6
    ISSN 2312-0541
    ISSN 2312-0541
    DOI 10.1183/23120541.00056-2022
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Pulmonary function test and computed tomography features during follow-up after SARS, MERS and COVID-19

    Christopher C. Huntley / Ketan Patel / Shahnoor-E-Salam Bil Bushra / Farah Mobeen / Michael N. Armitage / Anita Pye / Chloe B. Knight / Alyaa Mostafa / Marie Kershaw / Aishah Z. Mughal / Emily McKemey / Alice M. Turner / P. Sherwood Burge / Gareth I. Walters

    ERJ Open Research, Vol 8, Iss

    a systematic review and meta-analysis

    2022  Volume 2

    Abstract: Background The COVID-19 pandemic follows severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronavirus epidemics. Some survivors of COVID-19 infection experience persistent respiratory symptoms, yet their cause and ... ...

    Abstract Background The COVID-19 pandemic follows severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronavirus epidemics. Some survivors of COVID-19 infection experience persistent respiratory symptoms, yet their cause and natural history remain unclear. Follow-up after SARS and MERS may provide a model for predicting the long-term pulmonary consequences of COVID-19. Methods This systematic review and meta-analysis aims to describe and compare the longitudinal pulmonary function test (PFT) and computed tomography (CT) features of patients recovering from SARS, MERS and COVID-19. Meta-analysis of PFT parameters (DerSimonian and Laird random-effects model) and proportion of CT features (Freeman-Tukey transformation random-effects model) were performed. Findings Persistent reduction in the diffusing capacity for carbon monoxide following SARS and COVID-19 infection is seen at 6 months follow-up, and 12 months after MERS. Other PFT parameters recover in this time. 6 months after SARS and COVID-19, ground-glass opacity, linear opacities and reticulation persist in over 30% of patients; honeycombing and traction dilatation are reported less often. Severe/critical COVID-19 infection leads to greater CT and PFT abnormality compared to mild/moderate infection. Interpretation Persistent diffusion defects suggestive of parenchymal lung injury occur after SARS, MERS and COVID-19 infection, but improve over time. After COVID-19 infection, CT features are suggestive of persistent parenchymal lung injury, in keeping with a post-COVID-19 interstitial lung syndrome. It is yet to be determined if this is a regressive or progressive disease.
    Keywords Medicine ; R
    Language English
    Publishing date 2022-05-01T00:00:00Z
    Publisher European Respiratory Society
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: Evaluation of the Implementation of the 4C Mortality Score in United Kingdom hospitals during the second pandemic wave

    Blunsum, Andrew E / Perkins, Jonathan S. / Arshad, Areeb / Bajpai, Sukrit / Barclay-Elliott, Karen / Brito-Mutunayagam, Sanjita / Brooks, Rebecca / Chan, Terrence / Coates, Dominic / Corobana, Alina / Crocker-Buque, Tim / Evans, Terry John / Gordon-Brown, Jasmine / Hack, Berkin / Hiles, Heather / Khanijau, Aakash / Lalwani, Salina / Leong, Clare / MacKay, Kirsty /
    Macrae, Catriona / Martin, Bryony / Martin, Christopher A / McKemey, Emily / Nazareth, Joshua / Pan, Daniel / Scopazzini, Marcello / Simons, David / Swinhoe, Sophie / Thomas, Julia / Thorburn, Fiona / Walpole, Sarah / Warne, Esmie / Wilson, Rory / MacConnachie, Alisdair / Ho, Antonia

    medRxiv

    Abstract: ABSTRACT The 4C Mortality Score (4C Score) was designed to risk stratify hospitalised patients with COVID-19. We assessed inclusion of 4C Score in COVID-19 management guidance and its documentation in patients9 case notes in January 2021 in UK hospitals. ...

    Abstract ABSTRACT The 4C Mortality Score (4C Score) was designed to risk stratify hospitalised patients with COVID-19. We assessed inclusion of 4C Score in COVID-19 management guidance and its documentation in patients9 case notes in January 2021 in UK hospitals. 4C Score was included within guidance by 50% of sites, though score documentation in case notes was highly variable. Higher documentation of 4C Score was associated with score integration within admissions proformas, inclusion of 4C Score variables or link to online calculator, and management decisions. Integration of 4C Score within clinical pathways may encourage more widespread use.
    Keywords covid19
    Language English
    Publishing date 2021-12-19
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2021.12.18.21268003
    Database COVID19

    Kategorien

To top